,address1,city,state,zip,country,phone,fax,website,industry,sector,longBusinessSummary,fullTimeEmployees,companyOfficers,auditRisk,boardRisk,compensationRisk,shareHolderRightsRisk,overallRisk,governanceEpochDate,compensationAsOfEpochDate,maxAge,priceHint,previousClose,open,dayLow,dayHigh,regularMarketPreviousClose,regularMarketOpen,regularMarketDayLow,regularMarketDayHigh,payoutRatio,beta,forwardPE,volume,regularMarketVolume,averageVolume,averageVolume10days,averageDailyVolume10Day,bid,ask,bidSize,askSize,marketCap,fiftyTwoWeekLow,fiftyTwoWeekHigh,priceToSalesTrailing12Months,fiftyDayAverage,twoHundredDayAverage,trailingAnnualDividendRate,trailingAnnualDividendYield,currency,enterpriseValue,profitMargins,floatShares,sharesOutstanding,sharesShort,sharesShortPriorMonth,sharesShortPreviousMonthDate,dateShortInterest,sharesPercentSharesOut,heldPercentInsiders,heldPercentInstitutions,shortRatio,shortPercentOfFloat,bookValue,priceToBook,lastFiscalYearEnd,nextFiscalYearEnd,mostRecentQuarter,netIncomeToCommon,trailingEps,forwardEps,pegRatio,enterpriseToRevenue,enterpriseToEbitda,exchange,quoteType,symbol,underlyingSymbol,shortName,longName,firstTradeDateEpochUtc,timeZoneFullName,timeZoneShortName,gmtOffSetMilliseconds,currentPrice,targetHighPrice,targetLowPrice,targetMeanPrice,targetMedianPrice,recommendationMean,recommendationKey,numberOfAnalystOpinions,totalCash,totalCashPerShare,ebitda,totalDebt,quickRatio,currentRatio,totalRevenue,debtToEquity,revenuePerShare,returnOnAssets,returnOnEquity,grossProfits,freeCashflow,operatingCashflow,revenueGrowth,grossMargins,ebitdaMargins,operatingMargins,financialCurrency,trailingPegRatio
0,10260 Bubb Road,Cupertino,CA,95014-4166,United States,408 777 1417,408 777 3577,https://www.durect.com,Drug Manufacturers—Specialty & Generic,Healthcare,"DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogenous, orally bioavailable small molecule that is in Phase IIb clinical trial to play a regulatory role in lipid metabolism, stress and inflammatory responses, and cell death and survival to treat alcohol-associated hepatitis, as well as completed Phase Ib clinical trial to treat patients with nonalcoholic steatohepatitis. In addition, the company offers POSIMIR, a post-surgical pain product to deliver bupivacaine over three days in adults; and Methydur to treat attention deficit hyperactivity disorder. It markets and sells its ALZET lines through direct sales force in the United States, as well as through a network of distributors in Japan, Europe, and internationally. The company has strategic collaboration and other agreements with Virginia Commonwealth University Intellectual Property Foundation; Indivior UK Ltd.; and Innocoll Pharmaceuticals Limited. DURECT Corporation was incorporated in 1998 and is headquartered in Cupertino, California.",72,"{'maxAge': 1, 'name': 'Dr. James E. Brown D.V.M.', 'age': 65, 'title': 'Co-Founder, CEO, Pres & Director', 'yearBorn': 1957, 'fiscalYear': 2022, 'totalPay': 885861, 'exercisedValue': 0, 'unexercisedValue': 0}",9,2,6,7,6,1693526400,1672444800,86400,4,2.95,2.95,2.855,2.97,2.95,2.95,2.855,2.97,0.0,1.485822,-2.1021898,364687,364687,229945,229880,229880,2.85,2.88,2900,800,79488288,2.78,9.5,4.09164,3.4636,4.63075,0.0,0.0,USD,69523232,-1.8586501,24594706,27600100,2168583,1531176,1690761600,1693440000,0.078600004,0.01322,0.37408,12.54,0.088199995,0.223,12.914799,1672444800,1703980800,1688083200,-36108000,-1.56,-1.37,-0.11,3.579,-2.011,NCM,EQUITY,DRRX,DRRX,DURECT Corporation,DURECT Corporation,970147800,America/New_York,EDT,-14400000,2.88,41.0,12.0,29.8,32.0,1.8,buy,5,34745000,1.259,-34575000,22848000,0.87,0.972,19427000,415.418,0.828,-0.36565,-1.71112,16480000,-8052375,-29246000,0.002,-0.95501,-1.77974,-1.78633,USD,
1,10260 Bubb Road,Cupertino,CA,95014-4166,United States,408 777 1417,408 777 3577,https://www.durect.com,Drug Manufacturers—Specialty & Generic,Healthcare,"DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogenous, orally bioavailable small molecule that is in Phase IIb clinical trial to play a regulatory role in lipid metabolism, stress and inflammatory responses, and cell death and survival to treat alcohol-associated hepatitis, as well as completed Phase Ib clinical trial to treat patients with nonalcoholic steatohepatitis. In addition, the company offers POSIMIR, a post-surgical pain product to deliver bupivacaine over three days in adults; and Methydur to treat attention deficit hyperactivity disorder. It markets and sells its ALZET lines through direct sales force in the United States, as well as through a network of distributors in Japan, Europe, and internationally. The company has strategic collaboration and other agreements with Virginia Commonwealth University Intellectual Property Foundation; Indivior UK Ltd.; and Innocoll Pharmaceuticals Limited. DURECT Corporation was incorporated in 1998 and is headquartered in Cupertino, California.",72,"{'maxAge': 1, 'name': 'Ms. Judy R. Joice', 'age': 65, 'title': 'Sr. VP of Operations & Corp. Quality Assurance', 'yearBorn': 1957, 'fiscalYear': 2022, 'totalPay': 451816, 'exercisedValue': 0, 'unexercisedValue': 0}",9,2,6,7,6,1693526400,1672444800,86400,4,2.95,2.95,2.855,2.97,2.95,2.95,2.855,2.97,0.0,1.485822,-2.1021898,364687,364687,229945,229880,229880,2.85,2.88,2900,800,79488288,2.78,9.5,4.09164,3.4636,4.63075,0.0,0.0,USD,69523232,-1.8586501,24594706,27600100,2168583,1531176,1690761600,1693440000,0.078600004,0.01322,0.37408,12.54,0.088199995,0.223,12.914799,1672444800,1703980800,1688083200,-36108000,-1.56,-1.37,-0.11,3.579,-2.011,NCM,EQUITY,DRRX,DRRX,DURECT Corporation,DURECT Corporation,970147800,America/New_York,EDT,-14400000,2.88,41.0,12.0,29.8,32.0,1.8,buy,5,34745000,1.259,-34575000,22848000,0.87,0.972,19427000,415.418,0.828,-0.36565,-1.71112,16480000,-8052375,-29246000,0.002,-0.95501,-1.77974,-1.78633,USD,
2,10260 Bubb Road,Cupertino,CA,95014-4166,United States,408 777 1417,408 777 3577,https://www.durect.com,Drug Manufacturers—Specialty & Generic,Healthcare,"DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogenous, orally bioavailable small molecule that is in Phase IIb clinical trial to play a regulatory role in lipid metabolism, stress and inflammatory responses, and cell death and survival to treat alcohol-associated hepatitis, as well as completed Phase Ib clinical trial to treat patients with nonalcoholic steatohepatitis. In addition, the company offers POSIMIR, a post-surgical pain product to deliver bupivacaine over three days in adults; and Methydur to treat attention deficit hyperactivity disorder. It markets and sells its ALZET lines through direct sales force in the United States, as well as through a network of distributors in Japan, Europe, and internationally. The company has strategic collaboration and other agreements with Virginia Commonwealth University Intellectual Property Foundation; Indivior UK Ltd.; and Innocoll Pharmaceuticals Limited. DURECT Corporation was incorporated in 1998 and is headquartered in Cupertino, California.",72,"{'maxAge': 1, 'name': 'Dr. Norman L. Sussman M.D.', 'age': 69, 'title': 'Chief Medical Officer', 'yearBorn': 1953, 'fiscalYear': 2022, 'totalPay': 587945, 'exercisedValue': 0, 'unexercisedValue': 0}",9,2,6,7,6,1693526400,1672444800,86400,4,2.95,2.95,2.855,2.97,2.95,2.95,2.855,2.97,0.0,1.485822,-2.1021898,364687,364687,229945,229880,229880,2.85,2.88,2900,800,79488288,2.78,9.5,4.09164,3.4636,4.63075,0.0,0.0,USD,69523232,-1.8586501,24594706,27600100,2168583,1531176,1690761600,1693440000,0.078600004,0.01322,0.37408,12.54,0.088199995,0.223,12.914799,1672444800,1703980800,1688083200,-36108000,-1.56,-1.37,-0.11,3.579,-2.011,NCM,EQUITY,DRRX,DRRX,DURECT Corporation,DURECT Corporation,970147800,America/New_York,EDT,-14400000,2.88,41.0,12.0,29.8,32.0,1.8,buy,5,34745000,1.259,-34575000,22848000,0.87,0.972,19427000,415.418,0.828,-0.36565,-1.71112,16480000,-8052375,-29246000,0.002,-0.95501,-1.77974,-1.78633,USD,
3,10260 Bubb Road,Cupertino,CA,95014-4166,United States,408 777 1417,408 777 3577,https://www.durect.com,Drug Manufacturers—Specialty & Generic,Healthcare,"DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogenous, orally bioavailable small molecule that is in Phase IIb clinical trial to play a regulatory role in lipid metabolism, stress and inflammatory responses, and cell death and survival to treat alcohol-associated hepatitis, as well as completed Phase Ib clinical trial to treat patients with nonalcoholic steatohepatitis. In addition, the company offers POSIMIR, a post-surgical pain product to deliver bupivacaine over three days in adults; and Methydur to treat attention deficit hyperactivity disorder. It markets and sells its ALZET lines through direct sales force in the United States, as well as through a network of distributors in Japan, Europe, and internationally. The company has strategic collaboration and other agreements with Virginia Commonwealth University Intellectual Property Foundation; Indivior UK Ltd.; and Innocoll Pharmaceuticals Limited. DURECT Corporation was incorporated in 1998 and is headquartered in Cupertino, California.",72,"{'maxAge': 1, 'name': 'Mr. Timothy M. Papp M.B.A.', 'age': 46, 'title': 'CFO & Sec.', 'yearBorn': 1976, 'exercisedValue': 0, 'unexercisedValue': 0}",9,2,6,7,6,1693526400,1672444800,86400,4,2.95,2.95,2.855,2.97,2.95,2.95,2.855,2.97,0.0,1.485822,-2.1021898,364687,364687,229945,229880,229880,2.85,2.88,2900,800,79488288,2.78,9.5,4.09164,3.4636,4.63075,0.0,0.0,USD,69523232,-1.8586501,24594706,27600100,2168583,1531176,1690761600,1693440000,0.078600004,0.01322,0.37408,12.54,0.088199995,0.223,12.914799,1672444800,1703980800,1688083200,-36108000,-1.56,-1.37,-0.11,3.579,-2.011,NCM,EQUITY,DRRX,DRRX,DURECT Corporation,DURECT Corporation,970147800,America/New_York,EDT,-14400000,2.88,41.0,12.0,29.8,32.0,1.8,buy,5,34745000,1.259,-34575000,22848000,0.87,0.972,19427000,415.418,0.828,-0.36565,-1.71112,16480000,-8052375,-29246000,0.002,-0.95501,-1.77974,-1.78633,USD,
4,10260 Bubb Road,Cupertino,CA,95014-4166,United States,408 777 1417,408 777 3577,https://www.durect.com,Drug Manufacturers—Specialty & Generic,Healthcare,"DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogenous, orally bioavailable small molecule that is in Phase IIb clinical trial to play a regulatory role in lipid metabolism, stress and inflammatory responses, and cell death and survival to treat alcohol-associated hepatitis, as well as completed Phase Ib clinical trial to treat patients with nonalcoholic steatohepatitis. In addition, the company offers POSIMIR, a post-surgical pain product to deliver bupivacaine over three days in adults; and Methydur to treat attention deficit hyperactivity disorder. It markets and sells its ALZET lines through direct sales force in the United States, as well as through a network of distributors in Japan, Europe, and internationally. The company has strategic collaboration and other agreements with Virginia Commonwealth University Intellectual Property Foundation; Indivior UK Ltd.; and Innocoll Pharmaceuticals Limited. DURECT Corporation was incorporated in 1998 and is headquartered in Cupertino, California.",72,"{'maxAge': 1, 'name': 'Ms. Jian  Li M.B.A.', 'age': 52, 'title': 'Interim Principal Accounting Officer, Sr. VP of Fin., Corp. Controller & Sec.', 'yearBorn': 1970, 'fiscalYear': 2006, 'exercisedValue': 0, 'unexercisedValue': 0}",9,2,6,7,6,1693526400,1672444800,86400,4,2.95,2.95,2.855,2.97,2.95,2.95,2.855,2.97,0.0,1.485822,-2.1021898,364687,364687,229945,229880,229880,2.85,2.88,2900,800,79488288,2.78,9.5,4.09164,3.4636,4.63075,0.0,0.0,USD,69523232,-1.8586501,24594706,27600100,2168583,1531176,1690761600,1693440000,0.078600004,0.01322,0.37408,12.54,0.088199995,0.223,12.914799,1672444800,1703980800,1688083200,-36108000,-1.56,-1.37,-0.11,3.579,-2.011,NCM,EQUITY,DRRX,DRRX,DURECT Corporation,DURECT Corporation,970147800,America/New_York,EDT,-14400000,2.88,41.0,12.0,29.8,32.0,1.8,buy,5,34745000,1.259,-34575000,22848000,0.87,0.972,19427000,415.418,0.828,-0.36565,-1.71112,16480000,-8052375,-29246000,0.002,-0.95501,-1.77974,-1.78633,USD,
5,10260 Bubb Road,Cupertino,CA,95014-4166,United States,408 777 1417,408 777 3577,https://www.durect.com,Drug Manufacturers—Specialty & Generic,Healthcare,"DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogenous, orally bioavailable small molecule that is in Phase IIb clinical trial to play a regulatory role in lipid metabolism, stress and inflammatory responses, and cell death and survival to treat alcohol-associated hepatitis, as well as completed Phase Ib clinical trial to treat patients with nonalcoholic steatohepatitis. In addition, the company offers POSIMIR, a post-surgical pain product to deliver bupivacaine over three days in adults; and Methydur to treat attention deficit hyperactivity disorder. It markets and sells its ALZET lines through direct sales force in the United States, as well as through a network of distributors in Japan, Europe, and internationally. The company has strategic collaboration and other agreements with Virginia Commonwealth University Intellectual Property Foundation; Indivior UK Ltd.; and Innocoll Pharmaceuticals Limited. DURECT Corporation was incorporated in 1998 and is headquartered in Cupertino, California.",72,"{'maxAge': 1, 'name': 'Dr. WeiQi  Lin M.D., Ph.D.', 'title': 'Exec. VP of R&D and Principal Scientist', 'exercisedValue': 0, 'unexercisedValue': 0}",9,2,6,7,6,1693526400,1672444800,86400,4,2.95,2.95,2.855,2.97,2.95,2.95,2.855,2.97,0.0,1.485822,-2.1021898,364687,364687,229945,229880,229880,2.85,2.88,2900,800,79488288,2.78,9.5,4.09164,3.4636,4.63075,0.0,0.0,USD,69523232,-1.8586501,24594706,27600100,2168583,1531176,1690761600,1693440000,0.078600004,0.01322,0.37408,12.54,0.088199995,0.223,12.914799,1672444800,1703980800,1688083200,-36108000,-1.56,-1.37,-0.11,3.579,-2.011,NCM,EQUITY,DRRX,DRRX,DURECT Corporation,DURECT Corporation,970147800,America/New_York,EDT,-14400000,2.88,41.0,12.0,29.8,32.0,1.8,buy,5,34745000,1.259,-34575000,22848000,0.87,0.972,19427000,415.418,0.828,-0.36565,-1.71112,16480000,-8052375,-29246000,0.002,-0.95501,-1.77974,-1.78633,USD,
6,10260 Bubb Road,Cupertino,CA,95014-4166,United States,408 777 1417,408 777 3577,https://www.durect.com,Drug Manufacturers—Specialty & Generic,Healthcare,"DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogenous, orally bioavailable small molecule that is in Phase IIb clinical trial to play a regulatory role in lipid metabolism, stress and inflammatory responses, and cell death and survival to treat alcohol-associated hepatitis, as well as completed Phase Ib clinical trial to treat patients with nonalcoholic steatohepatitis. In addition, the company offers POSIMIR, a post-surgical pain product to deliver bupivacaine over three days in adults; and Methydur to treat attention deficit hyperactivity disorder. It markets and sells its ALZET lines through direct sales force in the United States, as well as through a network of distributors in Japan, Europe, and internationally. The company has strategic collaboration and other agreements with Virginia Commonwealth University Intellectual Property Foundation; Indivior UK Ltd.; and Innocoll Pharmaceuticals Limited. DURECT Corporation was incorporated in 1998 and is headquartered in Cupertino, California.",72,"{'maxAge': 1, 'name': 'Mr. Keith L. Lui M.B.A.', 'title': 'Sr. VP of Bus. Devel., Commercial & Medical Affairs', 'exercisedValue': 0, 'unexercisedValue': 0}",9,2,6,7,6,1693526400,1672444800,86400,4,2.95,2.95,2.855,2.97,2.95,2.95,2.855,2.97,0.0,1.485822,-2.1021898,364687,364687,229945,229880,229880,2.85,2.88,2900,800,79488288,2.78,9.5,4.09164,3.4636,4.63075,0.0,0.0,USD,69523232,-1.8586501,24594706,27600100,2168583,1531176,1690761600,1693440000,0.078600004,0.01322,0.37408,12.54,0.088199995,0.223,12.914799,1672444800,1703980800,1688083200,-36108000,-1.56,-1.37,-0.11,3.579,-2.011,NCM,EQUITY,DRRX,DRRX,DURECT Corporation,DURECT Corporation,970147800,America/New_York,EDT,-14400000,2.88,41.0,12.0,29.8,32.0,1.8,buy,5,34745000,1.259,-34575000,22848000,0.87,0.972,19427000,415.418,0.828,-0.36565,-1.71112,16480000,-8052375,-29246000,0.002,-0.95501,-1.77974,-1.78633,USD,
7,10260 Bubb Road,Cupertino,CA,95014-4166,United States,408 777 1417,408 777 3577,https://www.durect.com,Drug Manufacturers—Specialty & Generic,Healthcare,"DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogenous, orally bioavailable small molecule that is in Phase IIb clinical trial to play a regulatory role in lipid metabolism, stress and inflammatory responses, and cell death and survival to treat alcohol-associated hepatitis, as well as completed Phase Ib clinical trial to treat patients with nonalcoholic steatohepatitis. In addition, the company offers POSIMIR, a post-surgical pain product to deliver bupivacaine over three days in adults; and Methydur to treat attention deficit hyperactivity disorder. It markets and sells its ALZET lines through direct sales force in the United States, as well as through a network of distributors in Japan, Europe, and internationally. The company has strategic collaboration and other agreements with Virginia Commonwealth University Intellectual Property Foundation; Indivior UK Ltd.; and Innocoll Pharmaceuticals Limited. DURECT Corporation was incorporated in 1998 and is headquartered in Cupertino, California.",72,"{'maxAge': 1, 'name': 'Dr. Su Il Yum Ph.D.', 'age': 83, 'title': 'Exec. Officer', 'yearBorn': 1939, 'fiscalYear': 2012, 'exercisedValue': 0, 'unexercisedValue': 0}",9,2,6,7,6,1693526400,1672444800,86400,4,2.95,2.95,2.855,2.97,2.95,2.95,2.855,2.97,0.0,1.485822,-2.1021898,364687,364687,229945,229880,229880,2.85,2.88,2900,800,79488288,2.78,9.5,4.09164,3.4636,4.63075,0.0,0.0,USD,69523232,-1.8586501,24594706,27600100,2168583,1531176,1690761600,1693440000,0.078600004,0.01322,0.37408,12.54,0.088199995,0.223,12.914799,1672444800,1703980800,1688083200,-36108000,-1.56,-1.37,-0.11,3.579,-2.011,NCM,EQUITY,DRRX,DRRX,DURECT Corporation,DURECT Corporation,970147800,America/New_York,EDT,-14400000,2.88,41.0,12.0,29.8,32.0,1.8,buy,5,34745000,1.259,-34575000,22848000,0.87,0.972,19427000,415.418,0.828,-0.36565,-1.71112,16480000,-8052375,-29246000,0.002,-0.95501,-1.77974,-1.78633,USD,
